top of page
Search

8 Most Affordable Lung Cancer Treatment Centers in Faridabad for International Patients (2026)

3 hours ago
8 min read

Introduction

You just received a lung cancer diagnosis in a country far from home, and the first number that hits you is not the staging, but the bill. Your mind cycles through a single question: can I afford to fight this without bankrupting my family? Faridabad has emerged as a viable answer, offering lung cancer treatment packages starting as low as ₹200,000 to ₹2,500,000 depending on the protocol and facility tier.

This industrial city in the National Capital Region now houses several hospitals that cater specifically to medical travellers. They combine robotic surgery and SBRT with predictable cost structures.

The seven centres ahead bypass the marketing and get to the line items. Within these cost brackets, a standard package typically wraps in the surgeon's fee, a standard room, and routine inpatient care. Premium implants, extended ICU stays, or a private suite push the bill higher. Before you wire a deposit, the package exclusion list matters more than the sticker price.

Key Takeaways

The factors below determine whether your final invoice lands at the lower or upper end of India’s ₹2 lakh to ₹25 lakh spectrum.

  • Cost spectrum: Lung cancer treatment costs in Faridabad range from ₹200,000 to ₹2,500,000, depending on the complexity of the protocol.

  • Primary facilities: Dr. Bharat Patodiya’s practice, Sarvodaya Hospital, Asian Institute of Medical Sciences, Marengo Asia Hospitals, Metro Heart Institute, QRG Health City, and Park Hospital form the affordability map.

  • Room category: Opting for a general ward instead of a private suite slashes your daily tariff significantly.

  • Surgeon and systemic therapy: Senior surgical oncologists and targeted therapy agents such as osimertinib or crizotinib drive costs upward, but also directly affect progression-free survival outcomes.

  • International helplines: Sarvodaya’s 24/7 helpline at 9654511414 and Dr. Patodiya’s same-week consultation model offer rapid entry points for price estimates without physical travel.

1. Dr. Bharat Patodiya

Dr. Patodiya holds an ESMO certification and a DNB in Medical Oncology. His practice is built around giving medical travellers a single, direct line to a senior clinician.

  • Credentials matched to need: Focused certifications in lung cancer from Zurich University and GI cancer sit alongside breast cancer training from Ulm, Germany, rooting his work in sub-specialist knowledge.

  • Upfront package design: Treatment packages run from ₹2.5 lakh to ₹8 lakh, covering a full bundle of support services rather than a patchwork of separate fees.

  • Rapid entry for international cases: Same-week initial consultations cut the wait that often pushes patients toward more expensive choices they didn't plan for.

  • Second-opinion architecture: He coordinates formal second-opinion reviews at ₹2,000 to ₹5,000, whereas international review costs routinely reach several hundred dollars.

2. Dr. Bharat Patodiya’s Centre: Transparent, Personalised & International-Patient-First

The centre runs on a philosophy that hidden line items are a failure of consent. International patients walking in for a lung cancer workup encounter a practice designed to compress the time from first contact to treatment start.

Ground operations include home-based chemotherapy administration through certified nursing teams for regimens that qualify, and an in-house PET-CT support structure. Where conventional facilities charge ₹25,000 to ₹40,000 for a scan, the centre facilitates access at ₹5,000. That single saving can partially subsidize the first cycle of a generic maintenance drug.

Financial counsellors embedded in the practice do more than calculate a final bill. They verify Ayushman Bharat PM-JAY eligibility and extricate patients from the fear of being priced out of biomarker-directed therapy like crizotinib. The centre also screens international cases for clinical trial slots, a route that can save ₹5 lakh to ₹25 lakh compared with market-rate immunotherapy.

For patients cycling back home between maintenance doses, the 24/7 telemedicine channel converts post-chemotherapy fever protocols into actionable steps abroad. The aim is a treatment arc that does not punish you for living outside the Delhi NCR.

3. Sarvodaya Hospital, Sector-8 & Sector-19: Advanced Technology at a Predictable Cost

Sarvodaya runs two Faridabad sites. Its lung cancer program sits on a technology stack that, in many centres, makes the bill impossible to pin down ahead of time. Here, the modalities get packaged into defined cost bands.

Feature

Sarvodaya Hospital Details

Budget Implication

Key Surgical Oncologists

Dr. Dinesh Pendharkar (41+ years), Dr. Naveen Sanchety (19+ years)

Senior surgeon fees add to the line item but correlate with lower intraoperative complication risk.

Robotic-Assisted Surgery

Available within the hospital's surgical oncology program

Robotic platform maintenance costs raise the room fee compared with thoracoscopic VATS.

SBRT Availability

Stereotactic body radiotherapy offered

Precision reduces fraction counts versus conventional radiation, potentially offsetting the per-fraction premium.

Systemic Therapy

Chemotherapy, targeted therapy, immunotherapy all on-site

In-house pharmacy access enables negotiation on combination regimens.

International patients follow a single defined pathway. The 24/7 helpline (9654511414) routes into appointment booking and a direct "Write to Chairman" grievance channel that skips escalation queues. For someone pricing a regimen built around pembrolizumab and a platinum doublet, the dual-location setup means competitive quotes pulled from both Sector-8 and Sector-19 inventory.

4. Asian Institute of Medical Sciences: Thorough Multi-Modal Oncology Under One Roof

At AIMS, you complete surgery, chemotherapy, and radiation without getting billed for three separate facility gate fees.

  • Tumour board model: Once a week, a thoracic surgeon, radiation oncologist, and medical oncologist review your scans together. The protocol they settle on gets coded onto a single billing sheet, so what you pay maps directly to one care plan instead of three.

  • Modality stacking without facility duplication: You move from a lobectomy to adjuvant chemo to consolidation radiation without re-registering at a new centre or waiting for records to transfer. The administrative overhead that usually pushes up the cost of multi-step lung cancer treatment simply does not apply.

  • Centralized pharmacy logic: The in-house formulary is tied to volume-based procurement. When your protocol calls for a generic that costs 80% less than its branded equivalent, the pharmacy dispenses it by default because the centre's own purchasing economics favour the lower-cost option.

  • Logistical containment for international stays: Recovery between cycles happens in one geography. Housing, transport, and follow-up imaging consolidate around a single campus. The cost advantage extends well past the hospital invoice.

5. Marengo Asia Hospitals, Faridabad: Streamlined Pathways with Integrated Support Services

Marengo pre-defines its oncology pathways. That protocol logic means a treatment plan doesn't change direction mid-stream and inflate the budget along the way.

One coordinator handles the international patient desk: visa paperwork, airport pickup, and where you stay. A single point of contact replaces the usual chain of disconnected desks. That layer saves money most cost estimates ignore. Waiting three extra days in a hotel for a diagnostic slot adds up fast, and no hospital bill covers it.

Standardized chemotherapy and surgical protocols keep the quote close to the initial estimate. The hospital designs its lung cancer pathways with strict admission criteria and embedded monitoring, which holds down unplanned ICU admissions.

For someone starting concurrent chemoradiation for stage III NSCLC, the value is a predictable cost arc. The terror of a ballooning mid-treatment invoice disappears. The model fits medical travellers who need treatment to start on a fixed date, without administrative drift.

6. Metro Heart Institute with Multispeciality: Cardiology-Anchored Cancer Care Coordination

A lung cancer patient with a low ejection fraction or pre-existing coronary disease stands at a dangerous intersection. The cardiotoxic potential of cisplatin or the strain of a pneumonectomy can rapidly turn a staged admission into a cardiac crisis. Metro Heart Institute in Faridabad positions itself at this precise crossroads.

The hospital’s multispeciality structure allows a cardiologist to clear a patient for surgery on the same campus.

The coordination logic saves more than cardiac safety. It saves the cost of two separate pre-operative workups at two separate facilities. The institution’s brochure data frames the hospital as a centre that integrates oncology with high-acuity organ support, a configuration that directly reduces the per-day burn of an unplanned transfer to a cardiac ICU in an off-site hospital. For an international patient who has already been flagged with a borderline stress test, bypassing cardio-oncology fragmentation is not a luxury add-on. It is the difference between a defined budget and a catastrophic outlier event.

7. QRG Health City: Value-Driven Tiered Packages with Surgical Precision

QRG Health City adjusts the cost of lung cancer surgery by the exact bed you pick, the tools the surgeon uses, and the level of post-op monitoring included. On platforms like Lyfboat, you can see the surgeon’s fee, the implant grade, and the room category split across distinct payment tiers. That structured menu shows you the real cost drivers instead of wrapping everything into a single lump sum.

A general ward package with a standard thoracotomy set removes the robotic console fee and the private suite surcharge. For an early-stage lobectomy, that stripped-down option often delivers the same key oncologic result as the premium tier. The clinical baseline does not shift; what changes is the ancillary spending attached to comfort and surgical access method.

The tiers also lay out what each package excludes. A basic quote might leave out speech pathology consults, advanced pain management pumps, or a second intraoperative monitoring line. Spotting those gaps before admission means no reconciliation shock at the billing desk on discharge day.

For an international visitor who needs a concrete price tag next to each service layer, QRG turns a process that is often an opaque haggle into a simple checklist. Surgical volume matters in the maths. Centres with heavy thoracic throughput tend to post shorter ICU stays and fewer complications, and every day you are not in intensive care is a direct saving on the final invoice.

8. Park Hospital: Regional Accessibility with Core Oncology Capabilities

Park Hospital competes on the wallet, not on flashy tech specs.

If your oncologist has prescribed a standard carboplatin-paclitaxel regimen with adjuvant radiation, and the tumour does not call for a robotic surgeon, Park can run that entire protocol. You skip the capital-equipment surcharge that a quaternary centre bakes into its bill. The oncology unit lists chemotherapy delivery and general thoracic surgery as core capabilities, which covers the broad middle of lung cancer presentations.

The savings hit every line item. A lower daily room tariff, pharmacy charges that are moderate rather than premium, and slimmer markups on ancillary services add up. A three-cycle induction chemo block costs materially less here than at a flagship academic hospital.

Because Park sits outside the priciest pockets of Faridabad, accommodation for family members drops as well. For the patient with a straightforward plan, that is a real difference measured in rupees per cycle, not marketing language.

Conclusion

You have a spectrum: a same-week, transparency-first model on one end, technology-intensive cost bands in the middle, and stripped-down core protocol pricing on the accessible entry point.

The right choice maps your specific protocol to the institution whose cost structure aligns with it.

Do not guess. Call Sarvodaya’s 24/7 international helpline at 9654511414 or book an initial consultation for a line-by-line quote before you book a flight.

Frequently Asked Questions

Which hospitals or centres in Faridabad offer the most affordable lung cancer treatment for international patients?

Sarvodaya Hospital, Dr. Bharat Patodiya’s centre, Asian Institute of Medical Sciences, Marengo Asia Hospitals, Metro Heart Institute, QRG Health City, and Park Hospital all offer defined cost structures. Packages start at approximately ₹200,000 depending on the stage and required modalities.

What do typical lung cancer treatment packages in India cost and what is included?

Lung cancer treatment in Faridabad ranges from ₹200,000 to ₹2,500,000. Standard packages generally include the surgeon’s fee, a standard room, and routine inpatient care. Premium implants, extended ICU days, and private room upgrades are typically billed as separate line items.

How does Dr. Bharat Patodiya's centre support international patients seeking affordable cancer care?

The centre provides transparent packages starting at ₹2.5 lakh, same-week initial consultations, and PET-CT access at ₹5,000 versus the conventional ₹25,000 to ₹40,000. It also facilitates home-based chemotherapy for qualifying regimens and screens international patients for cost-reducing clinical trial slots.

What financial assistance, government schemes, or cost-saving options exist for cancer treatment in India?

Ayushman Bharat PM-JAY provides up to ₹5 lakh per family annually at empanelled hospitals and has reduced out-of-pocket expenditure by 21%. Clinical trial participation can save ₹5 lakh to ₹25 lakh. Generic cancer drugs also cost 80% less than branded equivalents once available.

How can an international patient get a second opinion or initial consultation quickly in Faridabad?

Several centres offer rapid remote pathways. Sarvodaya Hospital operates a 24/7 international helpline at 9654511414, and Dr. Bharat Patodiya’s centre provides formal second-opinion services priced at ₹2,000 to ₹5,000, alongside same-week consultation slots for international cases.

What non-chemotherapy options like targeted therapy and immunotherapy are available and how do they affect costs?

Targeted therapies such as gefitinib and dacomitinib, and immunotherapies like immune checkpoint inhibitors, are available. They increase per-cycle costs compared with chemotherapy, but in ALK-positive NSCLC, these agents improve QALYs, shifting the cost-effectiveness calculation away from purely upfront pricing.

Sources

 
 
 

Comments


bottom of page